Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration.
Isshiki M, Sakuma I, Hayashino Y, Sumita T, Hara K, Takahashi K, Shiojima I, Satoh-Asahara N, Kitazato H, Ito D, Saito D, Hatano M, Ikegami Y, Iida S, Shimada A, Noda M. Isshiki M, et al. Endocr J. 2020 Nov 28;67(11):1127-1138. doi: 10.1507/endocrj.EJ20-0222. Epub 2020 Jul 1. Endocr J. 2020. PMID: 32612066 Free article. Clinical Trial.
Differences in the birthweight of infants born to patients with early- or mid-to-late-detected gestational diabetes mellitus who underwent guideline-based glycemic control.
Yasuda S, Inoue K, Iida S, Oikawa Y, Namba A, Isshiki M, Inoue I, Kamei Y, Shimada A, Noda M. Yasuda S, et al. Among authors: isshiki m. J Diabetes Complications. 2021 Apr;35(4):107850. doi: 10.1016/j.jdiacomp.2021.107850. Epub 2021 Jan 9. J Diabetes Complications. 2021. PMID: 33483230
Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.
Fujita T, Ando K, Nishimura H, Ideura T, Yasuda G, Isshiki M, Takahashi K; Cilnidipine versus Amlodipine Randomised Trial for Evaluation in Renal Desease(CARTER) Study Investigators. Fujita T, et al. Among authors: isshiki m. Kidney Int. 2007 Dec;72(12):1543-9. doi: 10.1038/sj.ki.5002623. Epub 2007 Oct 17. Kidney Int. 2007. PMID: 17943080 Free article. Clinical Trial.
Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in Renin-Angiotensin System (RAS) inhibitor-treated hypertensive patients with albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics TreatMent with RAS inhibitOrs in a Chronic Kidney Disease Hypertensive Population) study.
Ando K, Nitta K, Rakugi H, Nishizawa Y, Yokoyama H, Nakanishi T, Kashihara N, Tomita K, Nangaku M, Takahashi K, Isshiki M, Shimosawa T, Fujita T. Ando K, et al. Among authors: isshiki m. Int J Med Sci. 2014 Jun 21;11(9):897-904. doi: 10.7150/ijms.9026. eCollection 2014. Int J Med Sci. 2014. PMID: 25013370 Free PMC article. Clinical Trial.
Mineralocorticoid receptor blockade suppresses dietary salt-induced ACEI/ARB-resistant albuminuria in non-diabetic hypertension: a sub-analysis of evaluate study.
Nishimoto M, Ohtsu H, Marumo T, Kawarazaki W, Ayuzawa N, Ueda K, Hirohama D, Kawakami-Mori F, Shibata S, Nagase M, Isshiki M, Oba S, Shimosawa T, Fujita T. Nishimoto M, et al. Among authors: isshiki m. Hypertens Res. 2019 Apr;42(4):514-521. doi: 10.1038/s41440-018-0201-7. Epub 2019 Jan 11. Hypertens Res. 2019. PMID: 30631161
100 results